Metabolic labeling of cellular proteins with noncanonical amino acids (ncAAs) has emerged as an important tool for the study of proteome dynamics.^[@ref1]−[@ref5]^ Bio-orthogonal noncanonical amino acid tagging (BONCAT)^[@ref6]^ uses metabolic incorporation of ncAAs into newly made proteins to enable their enrichment and subsequent identification by mass spectrometry. Newly synthesized proteins can be detected in fixed cells or cell lysates by \[3 + 2\]-cycloaddition reactions between the azide side-chain of an ncAA and alkynyl probes^[@ref7]−[@ref9]^ ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}a) or tagged for affinity enrichment and identified by tandem mass spectrometry ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}b). Recent studies have combined BONCAT with SILAC (stable isotope labeling with amino acids in cell culture)^[@ref10]^ to acquire quantitative information about protein synthesis in mammalian cell lines^[@ref11]−[@ref13]^ and to identify secreted proteins in serum-supplemented media.^[@ref14]^ These studies illustrate the utility of the BONCAT method in studies of proteome dynamics in mammalian cells.

The temporal resolution provided by metabolic labeling methods can be complemented by cell-selectivity through the controlled expression of mutant aminoacyl-tRNA synthetases. Initial studies of this kind were implemented in bacterial systems^[@ref15],[@ref16]^ and used to identify proteins injected into mammalian cells in the course of infection by the bacterial pathogen *Yersinia enterocolitica*.^[@ref17]^ More recently, cell-selective methods have been developed for use in *Caenorhabditis elegans*([@ref18]) and *Drosophila melanogaster*.^[@ref19]^ Extension of such methods to mammalian systems represents an attractive challenge.

Our cell-selective studies in bacterial systems used the L13N/Y260L/H301L mutant form of the *E. coli* methionyl-tRNA synthetase (which we designated NLL-MetRS) to activate the methionine surrogate [l]{.smallcaps}-azidonorleucine (Anl). Because wild-type MetRS does not activate Anl, BONCAT labeling occurs only in cells that express the NLL-MetRS. Although one might imagine using the NLL-MetRS for cell-selective Anl labeling of mammalian proteins ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}c), the *E. coli* enzyme charges only the initiator tRNA in mammalian cells; it does not charge elongator tRNA^Met^,^[@ref20]^ and Anl labeling is restricted to N-terminal positions in mammalian proteins. This observation prompted us to develop new MetRS variants to tag mammalian cell proteins with Anl.

![Targeted Expression of Mutant Aminoacyl-tRNA Synthetases (aaRS) for Cell-Selective BONCAT in Mammalian Cells\
(a) The azide side chain of Anl in proteins (R~1~) is chemoselectively tagged through azide--alkyne cycloaddition reactions. (b) Controlled expression of mutant aaRS in cells of interest restricts labeling to those cells and enables the detection and identification of proteins in a cell-selective manner. (c) The endogenous mammalian aaRS charges Met but not Anl. A mutant aaRS is used to charge Anl to tRNA^Met^.](ja-2015-08980f_0005){#sch1}

We investigated two complementary approaches to cell-selective incorporation of Anl into mammalian proteins. The first approach aimed to identify mutant mammalian aaRSs that would charge Anl to endogenous tRNA^Met^. The second approach involved coexpression of *E. coli* NLL-MetRS and *E. coli* elongator tRNA^Met^ in mammalian cells. Reports by RajBhandary and co-workers showing successful concomitant expression of an active *E. coli* glutaminyl-tRNA synthetase and a functional amber suppressor tRNA that is not aminoacylated *in vivo* by any mammalian aaRS suggested to us that the mammalian translation machinery might co-opt an *E. coli* elongator tRNA^Met^ that is charged by NLL-MetRS.^[@ref21],[@ref22]^ To identify mutant mammalian aaRSs that charge Anl to endogenous tRNA^Met^, we made a small mutant aaRS library. We had previously observed that residues 13, 260, and 301 in the Met-binding pocket of *E. coli* MetRS^[@ref23]^ can be mutated to enable activation of Anl.^[@ref24]^ Because there are no reported structures of mammalian MetRSs, we used sequence alignment to determine the corresponding positions in the *E. coli* and eukaryotic MetRS enzymes ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a). Conservation of the residues that align with *E. coli* residues 13, 260, and 301 suggested that site-directed mutagenesis at the corresponding positions in the mouse MetRS (*Mm*MetRS) would yield variants that charge Anl. Therefore, we constructed a small mutant library in which residues L274, Y527 and H562 of *Mm*MetRS ("LYH") were mutated to SLL, CLL, PLL, and NLL ([Figure S1--S6](#notes-1){ref-type="notes"}). We also made an L274G mutant, reflecting our earlier observation that the corresponding L13G variant of the *E. coli* MetRS activates Anl.^[@ref23]^ Finally, we overexpressed wild-type *Mm*MetRS to determine whether overexpression of the wild-type enzyme causes observable levels of incorporation of Anl into cellular proteins.

MetRS variants were expressed under control of a CMV promoter ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b). To express the *E. coli* elongator tRNA^Met^, we adopted the approach of the RajBhandary group and introduced 5′- and 3′-flanking sequences derived from human initiator tRNA to enable proper RNA editing^[@ref21]^ ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}c). Notably, efficient transcription by mammalian RNA polymerase III requires a purine at position 9 of the tRNA coding sequence. In this case, adenine was used. This adenine lies in the A box of the internal promoter of eukaryotic tRNA genes.^[@ref21]^ In mammalian cells, the 3′-CCA tail is added by a nucleotidyltransferase;^[@ref25]^ therefore, we tested tRNA sequences with and without CCA tails ([Figure S7--S9](#notes-1){ref-type="notes"}). We measured the activities of these constructs with respect to Anl incorporation by transiently transfecting several widely used mammalian cell lines, including Chinese hamster ovary (CHO) cells, monkey kidney cells (COS7), and an immortalized human cervical cancer cell line (HeLa). Cells were incubated in serum-containing medium supplemented with 1.5 mM Anl for 10 h and then lysed. Total cellular proteins were treated with alkyne-tetramethylrhodamine (TAMRA) ([Figure S10](#notes-1){ref-type="notes"}) for labeling via copper-catalyzed azide--alkyne cycloaddition (reaction 1, [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}a).^[@ref7],[@ref26],[@ref27]^ After SDS-PAGE, TAMRA-labeled proteins were detected by in-gel fluorescence imaging ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}d). As expected, Anl was not charged to any appreciable extent by the wild-type translational machinery. Anl incorporation was detected in cells carrying the *E. coli* NLL-MetRS, but we did not observe a significant increase in Anl incorporation as a function of tRNA expression. The variability of incorporation across different cell lines suggests that the expression levels of the tRNA and the synthetase may need to be optimized for each cell type, thereby limiting the general applicability of this approach. Nevertheless, variants of this strategy have already proven useful for cell-selective protein labeling: for example, Chin and co-workers have described successful proteome-wide labeling through the action of a genetically encoded pyrrolysyl-tRNA synthetase/tRNA pair in *Drosophila.*([@ref28])

In contrast to our results with the *E. coli* NLL-MetRS/tRNA^Met^ pair, expression of the L274G mouse MetRS, henceforth called L274G*Mm*MetRS, resulted in robust incorporation of Anl across all three cell lines. Thus, a single mutation is sufficient to enable Anl incorporation into mammalian cell proteins. Surprisingly, we found no evidence of significant Anl labeling with any of the triple mutants we examined ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}d).

![Identification of MetRS variants for metabolic labeling of mammalian proteins with Anl. (a) Sequence alignment of MetRS variants with positions 13, 260, and 301 of the *E. coli* MetRS highlighted. (b) Constructs for expression of MetRS and *E. coli* tRNA^Met^ under control of the CMV promoter and an internal eukaryotic tRNA promoter, respectively (c) *E. coli* tRNA^Met^ coding sequence carrying 5′- and 3′-flanking sequences derived from human initiator tRNA^Met^. (d) In-gel fluorescence image shows TAMRA labeling, which indicates Anl incorporation into cellular proteins. tRNA\* carries a 3′-CCA tail in the tRNA coding sequence. The wild-type mouse MetRS is indicated by WT and the ±Anl conditions correspond to empty vector labeling controls. The same gels were stained with colloidal blue dye ([Figure S11](#notes-1){ref-type="notes"}) for nonspecific labeling of all proteins.](ja-2015-08980f_0002){#fig1}

An important determinant of the utility of a mutant synthetase in ncAA tagging is the selectivity of the synthetase with respect to activation of the ncAA and its canonical counterpart. To provide a practical measure of the selectivity of L274G*Mm*MetRS, we examined protein labeling in CHO cells as a function of Anl concentration in serum-containing media. After Anl incorporation, proteins from cell lysates were labeled with alkyne-TAMRA ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a). We also performed Met competition assays by incubating CHO cells with 1.5 mM Anl in media supplemented with Met at different concentrations ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b). Assuming standard Michaelis--Menten kinetics for activation of both Met and Anl, we obtained the following expression (see [Figure S12](#notes-1){ref-type="notes"} for derivation):where *V* is the rate of activation of Anl, *K*^*A*^ and *K*^*M*^ are the specificity constants (*k*~cat~/*K*~*M*~)) for Anl and Met, respectively, and *C* is a constant. Fitting this equation to the measured intensities of in-gel TAMRA fluorescence (taken as a measure of the rate of incorporation of Anl into cellular proteins) yielded a value of *K*^*A*^/*K*^*M*^ of 0.25 (i.e., L274G*Mm*MetRS activates Met 4-fold faster than Anl at equimolar concentrations of the two substrates).

![Selectivity of L274G*Mm*MetRS. In-gel TAMRA fluorescence and Coomassie staining show Anl incorporation and total protein content, respectively. Fluorescence values were quantified and normalized to total protein levels. (a) Protein labeling in CHO media using the L274G*Mm*MetRS at different Anl concentrations. (b) Protein labeling using both the L274G*Mm*MetRS at increasing Met concentrations and 1.5 mM Anl. Plots on the bottom show Anl incorporation based on quantitated TAMRA fluorescence values. Error bars indicate standard deviation, and the dotted line represents line of best fit based on the equation above and was used to calculate selectivity.](ja-2015-08980f_0003){#fig2}

The ability to restrict L274G*Mm*MetRS expression to cells of interest should enable the cell-selective labeling of proteins for targeted analysis of protein synthesis. To validate this concept, we developed a reporter construct expressing both L274G*Mm*MetRS and mCherry under control of a CMV promoter (pMaRSC). A T2A linker was used to express two disjointed proteins in the same open reading frame; we reasoned that fusing L274G*Mm*MetRS and mCherry might alter the activity of the synthetase and confound protein labeling results ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a). As an additional control, we developed a similar expression construct without mCherry (pMaRS) ([Figures S13 and S14](#notes-1){ref-type="notes"}). When transfected into CHO cells, both constructs enabled labeling of cellular proteins at comparable levels, indicating that L274G*Mm*MetRS was functional in both contexts ([Figures S14 and S15](#notes-1){ref-type="notes"}). We used the mCherry signal to track expression of L274G*Mm*MetRS in pMaRSC-transfected cells. CHO cells transfected with pMaRSC and incubated with Anl (1.5 mM, 6 h) were fixed, permeabilized, and treated with alkyne-TAMRA. We observed TAMRA fluorescence exclusively in the mCherry-expressing cells, consistent with cell-selective incorporation of Anl into cellular proteins ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}b).

The CMV promoter drives constitutive expression of L274G*Mm*MetRS. To enable conditional expression of the synthetase, we developed a stable CHO cell line containing an L274G*Mm*MetRS-T2A-mCherry gene under control of a CMV promoter located just upstream of a loxP-flanked stop sequence ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}c). These cells were transiently transfected with a second (activating) construct bearing a strong Ef1α promoter that drives expression of an eGFP-Cre fusion protein.

![Cell-selective proteomic labeling and identification. (a) Design of pMaRSC and pMaRS constructs for the expression of L274G*Mm*MetRS and a C-terminal Myc-tagged mCherry marker to track synthetase expression. (b) Fluorescence confocal microscopy image of CHO cells containing the pMaRSC construct. DAPI shows the position of cell nuclei. (c) Fluorescence confocal microscopy image of CHO cells with a LoxP-flanked L274G*Mm*MetRS-T2A-mCherry sequence transiently transfected with an eGFP-Cre expression vector. The GFP signal identifies cells that express Cre; the mCherry signal marks cells in which L274G*Mm*MetRS is expressed. All mCherry+ cells show TAMRA labeling. The TAMRA and mCherry signal intensities are linearly correlated (*R*^2^ = 0.7), but the mCherry intensity falls below the threshold for visual detection in some cells. (d) Identification of Anl-labeled proteins by tandem mass spectrometry and annotation in terms of cellular components using STRAP software.^[@ref29]^ Proteins are listed in [Table S1](#notes-1){ref-type="notes"} and discussed more fully in [Figure S16](#notes-1){ref-type="notes"}.](ja-2015-08980f_0004){#fig3}

We used the eGFP signal to track expression of Cre and followed the mCherry signal to monitor recombination of the loxP sites. As expected, in the subset of cells that expressed Cre (as determined by the GFP signal), we observed both mCherry expression indicative of loxP recombination and TAMRA fluorescence from Anl-tagged cellular proteins, confirming that cell-selective proteomic labeling can be achieved through regulated transgene expression. These results suggest that targeted insertion of loxP-L274G*Mm*MetRS cassettes into the ROSA26 locus of mouse embryonic stem (ES) cells^[@ref30]^ should facilitate engineering of Cre-Lox mice in which tissue-selective proteomic studies can be performed.

To confirm the utility of L274G*Mm*MetRS as a tool for proteomic analysis in mammalian systems, we used azadibenzocyclooctyne-functionalized beads to capture (reaction 2, [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}a) and enrich Anl-labeled proteins from lysates of CHO cells that constitutively express the synthetase under CMV promoter control. After on-resin trypsinization of purified proteins, we analyzed the resulting tryptic peptides by tandem mass spectrometry ([Table S1](#notes-1){ref-type="notes"}). A total of 996 proteins were identified in Anl-treated samples in short (120 min) analyses on a linear trap quadrupole (LTQ) Orbitrap mass spectrometer. Of these proteins, 786 were not found in Met-treated controls. Enrichment was confirmed by the acquisition of 19-fold more spectral counts in analyses of Anl-treated samples as compared to controls. We detected proteins associated with a wide variety of cellular components, including nuclear, cytoskeletal, mitochondrial, and membrane proteins ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}d, [S16](#notes-1){ref-type="notes"}). MS analysis of the proteome of HeLa cells expressing L274G*Mm*MetRS identified 161 sites of Anl incorporation, 150 (93%) at internal Met positions ([Figure S18, Table S2](#notes-1){ref-type="notes"}). This ratio mirrors the distribution of Met sites across the proteome.

In summary, we find that the L274G*Mm*MetRS functions in a variety of mammalian cell lines and charges Anl at a rate sufficient for cell-selective proteomic analysis. Surprisingly, the single-site mutant is superior to all of the triple mutants we evaluated, including the murine orthologue of the *E. coli* NLL-MetRS used previously in cell-selective studies of protein synthesis.^[@ref15]^ A variant of L274G*Mm*MetRS has recently been used for cell-selective labeling of proteins in *Drosophila*,^[@ref19]^ and we suggest that targeted expression of this enzyme will provide a broadly useful approach to proteome and secretome analysis in subpopulations of mammalian and other eukaryotic cells.
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